DRAP Recall-KANADEX-N cream’s Substandard Batches
Date: October 24, 2025DRAP Recall Alert No.: II/S/10-25-101 Target Audience: – National Regulatory Field Force– Healthcare Professionals (Physicians, Pharmacists, Nurses)– […]
Date: October 24, 2025DRAP Recall Alert No.: II/S/10-25-101 Target Audience: – National Regulatory Field Force– Healthcare Professionals (Physicians, Pharmacists, Nurses)– […]
In the last week of September,2025 Drug regulatory authority of Pakistan has issued many recalls of substandard, misbranded and adulterated
Unregistered Indian-Origin Illegal & Unsafe Sildenafil Tablets (PENAGRA, VEGA, COBRA) Being Sold Illegally Recall Alert | September 12, 2025 DRAP
DRAP Recall Alert No.: I/S/09-25-59 Date of Action: 10th September 2025 Intended Audience: Regulatory Field Force of DRAP and Provincial
DRAP Alert No: I/S/08-25-56Date of Action: 20th August 2025Intended Audience: Regulatory Field Force of DRAP and Provincial Drug Control Departments
DRAP Alert No. II/S/08-25-55Action Date: 18 August 2025Target Audience: DRAP’s National Regulatory Field Force Provincial Drug Control Departments Hospitals, pharmacies,
DRAP RECALLS-BATCHES OF ‘TABLET FAMILA 28F’ DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORATORY KARACHI. Target Audience: DRAP’s national regulatory field force
DRAP RECALL ALERT OF “AMOXIL SUSPENSION AND AMOXIL FORTE SUSPENSION” due to complaint of Induction Seal. DRAP Alert No: II/V/08-25-53Date
On July 17, 2025, the FDA brought together a panel of experts to discuss the benefits and risks of hormone
DRAP recall ⚠️Substandard Medicines⚕️-27 June-2025 The Directorate of Drug Control (DDC) Punjab has notify DRAP (drug regulatory authority of Pakistan)
DRAP RECALL ⚠️The PRODUCTS CONTAINING HYDROXYPROGESTERONE CAPROATE💉 DRAP (Drug regulatory authority of Pakistan has recalled and suspends the registration of
DRAP Recalls: Substandard Medicine : Famobex Suspension by Cibex (Pvt.) Ltd. The Drug Regulatory Authority of Pakistan (DRAP) has issued
DRAP Recall Alert⚠️Recall of Substandard “Tovir 0.5mg Tablet” having Batch No. 55, Manufactured by M/s Adamjee Pharmaceuticals (Pvt.) Ltd, Karachi.
FDA approves ✔️ Tafasitamab-cxix for relapsed or refractory follicular lymphoma (FL) On June 18, 2025, The FDA has approved tafasitamab-cxix
Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews GRAND RAPIDS, Mich. – Meijer has issued
DRAP’s Action on Medroxyprogesterone Acetate in Response to Meningioma Concerns and US Lawsuits Amid the ongoing lawsuits in the US
DRAP RECALL ALERT-JUNE 2025 Drug regulatory authority of Pakistan (DRAP) is responsible for the regulation of drugs and therapeutic drugs
FDA approves Darolutamide for metastatic castration-sensitive prostate cancer FDA approves darolutamide for metastatic castration-sensitive prostate cancer on june 3, 2025.
VigiMobile app, a smart way to report ADR| Core of medical profession- essential to be known by every healthcare professional| Also get to known how to download the App.
Recall Alert-Homegrown Family Foods Issues Allergy Alert on Undeclared Milk in Shore Lunch Oven Style Breader & Batter Mix Homegrown